CardioFuture
Helping you stay on top of the latest developments in the cardiovascular industry.
Stay Up-to-Date with our Monthly CardioFuture Newsletter
Stay Up-to-Date with our Monthly CardioFuture Newsletter
July 8, 2020
Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaired neural signals between atrial and ventricular chambers in the heart. AV block can lead to irregular beat, and in some cases, increased risk......
July 8, 2020
Boston Scientific has been granted FDA 510(k) clearance for their LUX-Dx insertable cardiac monitor system. This long-term diagnostic device is used to detect arrhythmias from conditions such as atrial fibrillation, syncope, and cryptogenic stroke. The LUX-Dx’s multi-stage algorithm first detects potential arrhythmias, then verifies them. When an arrhythmia is verified, clinicians are immediately alerted, so......
July 6, 2020
According to the latest market analysis by iData Research, the U.S. atherectomy market is expected to remain as one of the biggest contributors to the growth of the peripheral vascular market. While often performed in conjunction with other procedures, such as angioplasties, atherectomy procedures have been experiencing double-digit growth rates for the past two years......
July 3, 2020
According to the latest market analysis by iData Research, there were over 12,000 intravascular lithotripsy procedures performed in the United States in 2020. This number is expected to experience incredible growth and double in number by 2026. This growth can be attributed to two main factors: the creation of procedure codes by CMS, and successful......
June 5, 2020
Abiomed has been granted FDA emergency use authorization for its Impella RP – a temporary heart pump to support circulatory system functioning in patients with right side ventricular failure. The FDA has granted EUA for this device to treat COVID-19 patients, as some of them have suffered from right heart failure due to the virus,......
June 2, 2020
According to the latest vascular access device and accessories market analysis by iData Research, there are over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year in the United States. The overall US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026.......
May 28, 2020
According to the latest market analysis by iData Research, the US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. One of the biggest contributors to this growth will be the PICC, CVC, and PIVC line insertion and securement accessories market. This market growth is primarily......
May 6, 2020
Terumo Aortic, a company that focuses exclusively on producing devices regarding aorta, has developed the Thoraflex Hybrid to aid patients who have suffered from a thoracic aortic aneurysm, or a tear in the aortic vessel wall. These conditions are often fatal, and have low survival rates, even when patients receive prompt medical care. The device......
May 5, 2020
Vancouver-based company Lungpacer Medical has developed a single-use multi-electrode stimulating catheter that is inserted into the left subclavicle vein. It is used to stimulate the left and right phrenic nerves, providing support to the functioning of the diaphragm in patients who have respiratory issues. The device is paired with an external, reusable control unit to......
April 21, 2020
The Center for Medicare and Medicaid Services (CMS) is reissuing new guidelines for states and regions seeing declining and stabilizing COVID-19 infection rates and recommending healthcare facilities in these areas to resume providing elective procedures to patients without COVID-19 symptoms. On March 18, 2020, the CMS announced they would postponing non-essential medical and surgical procedures......
April 16, 2020
Welcome to the analyst interview series where we take a closer look at specific markets and try to understand how they are being impacted by the COVID-19 virus. Through asking our market analysts a series of questions, we attempt to get an in-depth look at the current state of the market while uncovering critical market......
April 1, 2020
Bardy Diagnostics‘ Carnation Ambulatory Monitor (CAM™) Patch is being used by Seattle health care workers to monitor heart beat and measure QT segments in coronavirus patients prescribed HCQ experimentally. HCQ was recently authorized to treat coronavirus patients by the FDA under the Emergency Use Authorization. HCQ is commonly used to treat malaria, lupus and rheumatoid......
March 25, 2020
CMS Postponing Non-Essential Medical, Surgical, and Dental Procedures The European Society of Cardiology (ESC), the American Heart Association (AHA), the Heart Failure Society of American (HFSA) and American College of Cardiology (ACC) have issued official statements clarifying that ACE-i and ARBs have not been found to increase COVID-19 mortality rates. Physicians are recommending coronavirus patients......
March 24, 2020
CMS Postponing Non-Essential Medical, Surgical, and Dental ProceduresAt the White House Task Force Press Briefing last week, the Center for Medicare & Medicaid Services (CMS) announced that all non-essential medical, surgical and dental procedures would be postponed until further notice in order to shift priorities to treating those affected by the coronavirus outbreak. The decision......
March 4, 2020
AI Predicts Heart Failure Hospitalization up to 10 Days in Advance PhysIQ and U.S. Veteran’s Affairs have published successful clinical trial results showing how artificial intelligence (AI) can be used to predict heart failure hospitalization up to 10 days in advance. The study, published in Circulation: Heart Failure, assesses PhysIQ’s pinpointIQ™ continuous data collection and......
February 26, 2020
Bioengineers at Trinity College Dublin have engineered artificial tissue patches that imitate the natural electrical conductivity of heart tissue while being structurally designed to withstand the movement of a beating heart. In addition to improving electrical signalling throughout the heart, the patches promote new cell growth and development to help heal damaged heart cells. The......
February 19, 2020
Overview Over the past decade, endovascular aortic repair (EVAR) has become the dominant technique for treatment, composing over 77% of aortic repairs in 2019. Developed in 1990, this procedure has undergone drastic changes in efficacy over the past decade due to advancements in graft technology and manufacturing techniques. The employment of computerized tomography (CT) scans......
February 12, 2020
The FDA has announced approval and authorization of Caption Health‘s AI software, Caption Guidance, to analyze and assist with cardiac ultrasounds (echocardiography). Heart disease kills approximately one out of every four Americans each year according to the Center for Disease Control and Prevention. Electrocardiograms (ECGs), Holter monitors and echocardiograms are most commonly used to identify......
February 5, 2020
World’s First Transcatheter Mitral Valve Approved in Europe Abbott‘s Tendyne system is the world’s first transcatheter mitral valve replacement (TMVR) technology to receive commercial clearance, obtaining the European CE mark earlier this week. The Abbott Tendyne TMVR system works in conjunction with Abbott’s MitraClip and offers an alternative, minimally invasive technique to correct mitral regurgitation......
January 29, 2020
The Center for Medicare & Medicaid Services (CMS) has proposed a permanent home infusion benefit available to Medicare patients as earlier as 2021. The home infusion benefit lies within the health payment rule which was finalized in November. Treatments such as chemotherapy, immune-deficient, and anti-infective treatments will all be covered by Medicare and accessible from......
January 8, 2020
This week Abbott announced that the U.S. FDA has given approval of a new alternative surgical technique for their HeartMate 3 heart pump. The procedure is designed to allow more advanced heart failure patients to avoid open heart surgery. The new, less invasive approach is designed to provide surgeons a choice in surgical method for......
January 7, 2020
Vascular Graft Solutions (VGS), an Israeli-based interventional cardiology company that specalizes in improving the outcomes of coronary and peripheral bypass surgeries, has announced the acquisition of several patent families from NEOGRAFT Technologies Inc. Included are patents that were previously developed and owned by Kips Bay Medical Inc., who pioneered in venous external stenting and vascular......
December 11, 2019
In a recent development, France-based Vygon Group, has acquired Italy-based Pilot. The purpose of the transaction was to obtain Pilot’s ECG location and navigation technology from their Pilot TLS product. The device ensures a safe insertion of central venous catheters (CVC) through precision and accuracy. The end result is optimal positioning of the distal tip......
December 4, 2019
It reduces reinterventions, and maintains access for end-stage renal disease for patients that have to undergo dialysis. This is what the clinical information highlighted for Medtronic’s latest product in the drug-coated balloon market, the IN.PACT AV DCB. The IN.PACT AV DCB delivers a proven anti-proliferative drug paclitaxel. This delivery increases the flow of blood and......
November 27, 2019
Tokyo-based OrbusNeich Medical K.K., has received Shonin approval by the Ministry of Health Labour, and Welfare (MHLW) for their COMBO Plus Coronary Stent. This new entrant into the coronary stent segment of the interventional cardiology market is designed to address risks correlated to delayed healing times found with conventional drug-eluting stents (DES). If left unresolved,......
